A federal district court in North Carolina denied Liquidia Technologies Inc.'s motion to dismiss United Therapeutics Corp.'s action for infringement of a patent that discloses a method of treating pulmonary hypertension. The court determined that the infringement claims aren’t barred by the rule against claim-splitting, the first-filed rule, or preclusion.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.